NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
19.85
+0.89 (4.69%)
At close: Jul 3, 2025, 1:00 PM
19.86
+0.01 (0.05%)
After-hours: Jul 3, 2025, 3:40 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $2.23 billion as of July 3, 2025. Its market cap has increased by 38.82% in one year.
Market Cap
2.23B
Enterprise Value
1.42B
1-Year Change
38.82%
Ranking
Category
Stock Price
$19.85
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.23B, an increase of 1,342.91%. That is a compound annual growth rate of 83.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 2.23B | -19.00% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.55B |
| Johnson & Johnson | 375.15B |
| AbbVie | 335.60B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 295.85B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 237.07B |
| AstraZeneca | 221.11B |